Harbor Investment Advisory’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,685
| Closed | -$118K | – | 1136 |
|
|
2024
Q3 | $118K | Hold |
1,685
| – | – | 0.01% | 422 |
|
|
2024
Q2 | $139K | Hold |
1,685
| – | – | 0.01% | 385 |
|
|
2024
Q1 | $147K | Hold |
1,685
| – | – | 0.02% | 386 |
|
|
2023
Q4 | $162K | Hold |
1,685
| – | – | 0.02% | 356 |
|
|
2023
Q3 | $149K | Hold |
1,685
| – | – | 0.02% | 345 |
|
|
2023
Q2 | $146K | Hold |
1,685
| – | – | 0.02% | 412 |
|
|
2023
Q1 | $164K | Hold |
1,685
| – | – | 0.02% | 389 |
|
|
2022
Q4 | $174K | Hold |
1,685
| – | – | 0.03% | 362 |
|
|
2022
Q3 | $143K | Hold |
1,685
| – | – | 0.02% | 391 |
|
|
2022
Q2 | $140K | Sell |
1,685
-91
| -5% | -$7.56K | 0.02% | 410 |
|
|
2022
Q1 | $137K | Sell |
1,776
-636
| -26% | -$49.1K | 0.02% | 458 |
|
|
2021
Q4 | $213K | Hold |
2,412
| – | – | 0.03% | 364 |
|
|
2021
Q3 | $186K | Hold |
2,412
| – | – | 0.03% | 380 |
|
|
2021
Q2 | $201K | Hold |
2,412
| – | – | 0.03% | 368 |
|
|
2021
Q1 | $182K | Buy |
2,412
+1,685
| +232% | +$127K | 0.03% | 355 |
|
|
2020
Q4 | $64K | Sell |
727
-1,274
| -64% | -$112K | 0.01% | 568 |
|
|
2020
Q3 | $152K | Buy |
2,001
+406
| +25% | +$30.8K | 0.03% | 316 |
|
|
2020
Q2 | $197K | Buy |
1,595
+1,354
| +562% | +$167K | 0.04% | 261 |
|
|
2020
Q1 | $20K | Buy |
+241
| New | +$20K | 0.01% | 573 |
|